Patent · US Expired

Polycyclic guanine phosphodiesterase V inhibitors

US6969719B2 · kind B2 · utility

44Cited by

17References

26Claims

0Family size

Assignee

SCHERING CORPORATION · US

Inventors

Theodros Asberom · West Orange, US
Yueqing Hu · Kowloon, CN
Dmitri Pissarnitski · Scotch Plains, US
Ruo Xu · Watchung, US
Yuguang Wang · Shanghai, CN
Samuel Chackalamannil · Califon, US
John W. Clader · Cranford, US
Andrew Stamford · Madison, US

Key dates

Filing date	Aug 26, 2002
Grant date	Nov 29, 2005
Priority date	—
Expiry date	Nov 29, 2022

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A polycyclic guanine phosphodiesterase V inhibitor having the formula (I.1) or (II.1), with the variables defined herein, which is useful for treating sexual dysfunction and other physiological disorders: A representative example is:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.